Author: marketing@sanfordguide.com

August ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   August 2019 From CDC Updated recommendations from the CDC Read More …

Sanford Guide Announces Integration with MD Labs

  Sperryville, VA – Sanford GuideĀ® announces the availability of its industry-leading infectious diseases guidelines through MD LabsĀ® Results Reports. This new integration, facilitated by Sanford Guide’s content delivery API, links to pertinent Sanford Guide content directly from the report to help guide appropriate antimicrobial selection and dosing. “Interpreting lab results within the context of Read More …

July ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   July 2019 New Antimicrobial Drug Approvals Recarbrio (imipenem/cilastatin/relebactam), approved Read More …

June ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   June 2019 CDC Health Advisory CDC is expecting a 3 Read More …

May ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   May 2019   New Print Editions Now Available Sanford Read More …

April ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   April 2019   Improved Sanford Guide Organization & Features Read More …

March ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   March 2019 New or Updated Treatment Guidelines Updated guidelines Read More …

February ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   February 2019 Post-licensure Safety Surveillance of Shingrix Recombinant adjuvanted Read More …

Sanford Guide Celebrates 50 Years of Antimicrobial Stewardship

  Sperryville, VA – Sanford Guide, the leading reference for the treatment of infectious diseases, celebrates its fiftieth year in 2019 with a renewed focus on providing clinically actionable guidance through digital platforms. While the company continues to update its ubiquitous print guides annually, advances in technology have enabled the development of market-leading mobile apps, Read More …

January ID Update

Sanford Guide ID Update features current developments in infectious diseases, curated by the Sanford Guide Editorial Board. Links marked with an asterisk (*) provide details to Web Edition subscribers, while all other links are universal. If you received this message from a colleague, subscribe now.   January 2019 Drug Safety Communications Following a review of Read More …